1. Glutamatergic system components as potential biomarkers and therapeutic targets in cancer in non-neural organs
   Ana Cristina García-Gaytán et al, 2022, Frontiers in Endocrinology CrossRef
2. Metabolomics analysis identifies lysine and taurine as candidate prognostic biomarkers for AML-M2 patients
   Xuan Zhou et al, 2020, International Journal of Hematology CrossRef
3. High Expression of CLEC11A Predicts Favorable Prognosis in Acute Myeloid Leukemia
   Chengliang Yin et al, 2021, Frontiers in Oncology CrossRef
4. Targeting Amino Acid Metabolic Vulnerabilities in Myeloid Malignancies
   Livingstone Fultang et al, 2021, Frontiers in Oncology CrossRef
5. Molecular subtyping of acute myeloid leukemia through ferroptosis signatures predicts prognosis and deciphers the immune microenvironment
   Denggang Fu et al, 2023, Frontiers in Cell and Developmental Biology CrossRef
6. Investigation of distinct gene expression profile patterns that can improve the classification of intermediate-risk prognosis in AML patients
   Nasr Eshibona et al, 2023, Frontiers in Genetics CrossRef
7. Six-gene signature for predicting survival in patients with head and neck squamous cell carcinoma
   Juncheng Wang et al, 2020, Aging CrossRef
8. Establishment of Prognosis Model in Acute Myeloid Leukemia Based on Hypoxia Microenvironment, and Exploration of Hypoxia-Related Mechanisms
   Jinman Zhong et al, 2021, Frontiers in Genetics CrossRef
9. The Role of Cystine/Glutamate Antiporter SLC7A11/xCT in the Pathophysiology of Cancer
   Nidhi Jyotsana et al, 2022, Frontiers in Oncology CrossRef
10. Identification of hub genes and potential molecular mechanisms related to drug sensitivity in acute myeloid leukemia based on machine learning
    Boyu Zhang et al, 2024, Frontiers in Pharmacology CrossRef